{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-161685","form_type":"8-K","ticker":"TPST","cik":"0001544227","company_name":"Tempest Therapeutics, Inc.","filed_at":"2024-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.912705+00:00","generated_at":"2026-06-01T04:18:57.019304+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Tempest Therapeutics announces 2024 annual meeting voting results","bullets":["Stockholders elected Stephen Brady, Michael Raab, and Ronit Simantov as Class III directors for three-year terms.","Advisory vote on named executive officer compensation passed with 7,466,910 for, 167,307 against, 275,440 abstentions.","Ratification of Ernst & Young as independent auditor for FY2024 approved with 14,040,756 for, 132,300 against, 21,465 abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-161685","json":"https://secwatch.observer/filing/0001193125-24-161685.json","markdown":"https://secwatch.observer/filing/0001193125-24-161685.md","text":"https://secwatch.observer/filing/0001193125-24-161685.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1544227/000119312524161685/0001193125-24-161685-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1544227/000119312524161685/d853541d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:18:57.019304+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}